WuXi Biologics (Cayman) (MEX:2269N) Common Stock: MXN1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:2269N WuXi Biologics (Cayman) Inc MEX:2269N
97 GF Score
Price MXN62.53
GF Value MXN54.50
! 5 Warning Signs
View Full Analysis

What is WuXi Biologics (Cayman) Common Stock?

WuXi Biologics (Cayman) MEX:2269N 97 Common Stock is MXN1 Mil as of Dec. 2025. GuruFocus rates MEX:2269N with a GF Score™ of 97/100 and a GF Value™ of MXN54.50. The stock has 5 warning signs investors should review.

WuXi Biologics (Cayman)'s quarterly common stock declined from Dec. 2024 (MXN1 Mil) to Jun. 2025 (MXN1 Mil) and declined from Jun. 2025 (MXN1 Mil) to Dec. 2025 (MXN1 Mil).

WuXi Biologics (Cayman)'s annual common stock increased from Dec. 2023 (MXN1 Mil) to Dec. 2024 (MXN1 Mil) but then declined from Dec. 2024 (MXN1 Mil) to Dec. 2025 (MXN1 Mil).

WuXi Biologics (Cayman) Common Stock Historical Data

* Premium members only.

The historical data trend for WuXi Biologics (Cayman)'s Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi Biologics (Cayman) Common Stock Chart

WuXi Biologics (Cayman) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.65 0.56 0.65 0.58

WuXi Biologics (Cayman) Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.58 0.65 0.59 0.58
MEX:2269N
97GF Score
WuXi Biologics (Cayman) Inc MEX:2269N
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WuXi Biologics (Cayman) Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of MXN1 Mil mean?
WuXi Biologics (Cayman) (MEX:2269N) has a Common Stock of MXN1 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on WuXi Biologics (Cayman) and its competitors.
Is WuXi Biologics (Cayman)'s Common Stock too high?
WuXi Biologics (Cayman)'s current Common Stock is MXN1 Mil. Overall, WuXi Biologics (Cayman) has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does WuXi Biologics (Cayman)'s Common Stock compare to VRTX and REGN?
WuXi Biologics (Cayman)'s Common Stock of MXN1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on WuXi Biologics (Cayman) and its competitors. WuXi Biologics (Cayman)'s current Common Stock is MXN1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi Biologics (Cayman) stock overvalued right now?
WuXi Biologics (Cayman) (MEX:2269N) has a current Common Stock of MXN1 Mil. The stock's GF Value™ is MXN54.50, compared to a current price of MXN62.53 — trading 14.7% above its estimated fair value. The current Common Stock is MXN1 Mil. WuXi Biologics (Cayman)'s overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For WuXi Biologics (Cayman) (MEX:2269N), the current Common Stock is MXN1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WuXi Biologics (Cayman) (MEX:2269N) Overvalued in 2026?

Based on GuruFocus' analysis, WuXi Biologics (Cayman) stock appears to be overvalued. The current stock price of MXN62.53 is trading 14.7% above its estimated GF Value™ of MXN54.50.

Key valuation signals for MEX:2269N:

  • Common Stock: MXN1 Mil
  • GF Value™: MXN54.50 vs. price of MXN62.53 (14.7% above fair value)
  • GF Score™: 97/100 with 5 warning signs

No single metric tells the full story. See the MEX:2269N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

WuXi Biologics (Cayman) Business Description

Address No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092
WuXi Biologics is one of the largest biologics contract development and manufacturing organizations in the world. Incorporated in 2014 following the reorganization of WuXi PharmaTech, WuXi engages in full-lifecycle services beginning from drug discovery, clinical trials, and commercial manufacturing. It focuses on developing refining and manufacturing processes to increase scalability and efficiency for pharmaceutical companies looking to outsource and access specialized knowledge. As of 2024, WuXi derives more than 60% of its revenue from US companies and focuses its operations on high-growth, late-stage, and commercial projects in the biologics sector. WuXi competes with Samsung Biologics, Lonza, and Fujifilm for contracts.
97GF Score

Get the complete analysis for MEX:2269N

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN62.53
Price
MXN54.50
GF Value